1. Home
  2. NVAX vs TRMD Comparison

NVAX vs TRMD Comparison

Compare NVAX & TRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • TRMD
  • Stock Information
  • Founded
  • NVAX 1987
  • TRMD 1889
  • Country
  • NVAX United States
  • TRMD United Kingdom
  • Employees
  • NVAX N/A
  • TRMD N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • TRMD Marine Transportation
  • Sector
  • NVAX Health Care
  • TRMD Consumer Discretionary
  • Exchange
  • NVAX Nasdaq
  • TRMD Nasdaq
  • Market Cap
  • NVAX 1.3B
  • TRMD 1.7B
  • IPO Year
  • NVAX 1995
  • TRMD N/A
  • Fundamental
  • Price
  • NVAX $7.34
  • TRMD $15.98
  • Analyst Decision
  • NVAX Buy
  • TRMD Buy
  • Analyst Count
  • NVAX 5
  • TRMD 1
  • Target Price
  • NVAX $19.00
  • TRMD $23.00
  • AVG Volume (30 Days)
  • NVAX 14.2M
  • TRMD 799.2K
  • Earning Date
  • NVAX 05-08-2025
  • TRMD 05-08-2025
  • Dividend Yield
  • NVAX N/A
  • TRMD 25.01%
  • EPS Growth
  • NVAX N/A
  • TRMD N/A
  • EPS
  • NVAX 2.97
  • TRMD 4.74
  • Revenue
  • NVAX $1,254,962,000.00
  • TRMD $1,444,200,000.00
  • Revenue This Year
  • NVAX $40.01
  • TRMD N/A
  • Revenue Next Year
  • NVAX N/A
  • TRMD N/A
  • P/E Ratio
  • NVAX $2.47
  • TRMD $3.51
  • Revenue Growth
  • NVAX 25.92
  • TRMD N/A
  • 52 Week Low
  • NVAX $5.01
  • TRMD $13.60
  • 52 Week High
  • NVAX $23.86
  • TRMD $40.47
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 55.86
  • TRMD 39.74
  • Support Level
  • NVAX $6.84
  • TRMD $16.66
  • Resistance Level
  • NVAX $7.62
  • TRMD $17.51
  • Average True Range (ATR)
  • NVAX 0.55
  • TRMD 0.46
  • MACD
  • NVAX 0.07
  • TRMD -0.19
  • Stochastic Oscillator
  • NVAX 50.52
  • TRMD 7.31

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About TRMD TORM plc

TORM PLC operates as a shipping company. The company owns and operates product tankers. It is engaged in the transportation of refined oil products The company transports clean petroleum products including gasoline, jet fuel, naphtha, and diesel oil, as well as other clean products. Its segments include the Tanker segment, and Marine Engineering segment. The company derives maximum revenue from Tanker segment.

Share on Social Networks: